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Cardiovascular disease is the leading cause of death for men and 
postmenopausal women in the United States. Estrogen is thought to be 
cardioprotective. An important action of estrogen is increasing endothelial-
dependent vasodilation of coronary arteries. Because of their estrogen-like 
components and activities, phytoestrogens, especially isoflavones such as 
genistein found in high concentrations in soy products, are being studied as 
a potential means to prevent cardiovascular disease and as an alternative to 
estrogen replacement therapy. In the current study we examined the effects of 
high dietary genistein on vascular function of mice. Since genistein is 
considered estrogenic, we hypothesized that genistein also would enhance 
vasodilation. Mice were divided into three diet groups: standard fed (200 mg 
genistein), high genistein (600 mg), and genistein-free (0 mg). After being 
on their respective diets for at least one month, the mice were sacrificed, 
thoracic aortas were isolated, cleaned of surrounding fat and connective 
tissue, and then cut into rings to measure contractile capacity. Receptor 
independent contractility was measured by adding increasing doses of 
potassium chloride (KCl). Both males and females fed 600 mg genistein showed 
significantly greater force of contractions at all doses of KCl above 30mM 
compared to other groups. The 0 mg group exhibited the least amount of 
tension for all KCl doses. Receptor dependent contractility was measured 
following increasing concentrations of norepinephrine (NE) in the presence 
and absence of NG-nitro-L-arginine methyl esther (L-NAME), a nitric oxide 
synthase (NOS) inhibitor. In the absence of L-NAME contractile responses to 
NE followed the KCl pattern for diet groups except for the 600 mg male group 
which was similar to the standard fed males. Therefore, the NE curves were 
normalized to the maximal KCl force. Normalization of NE to KCl indicated NE 
responses were similar for all groups except 600 mg males. To evaluate 
whether endothelial vasodilators alter contractile force mediated by NE, data 
were collected in the presence of L-NAME. The NE contractile responses with 
L-NAME were significantly greater than contractility without L-NAME for all 
groups. NOS contribution to vasodilation was significantly less in males 
compared to females. In females the contribution of NOS appeared greatest in 
the 600 mg group compared to other groups. These results show that 
vasodilation capacity is increased with high genistein (600 mg) diets with 
females, but not males. Surprisingly genistein significantly increased 
contractile force to KCl. Possible mechanisms that may underlie genistein 
effects on KCl contractions include increased L-type calcium currents and/or 
smooth muscle hypertrophy/hyperplasia. 
 
